Dermatology News and Research

Latest Dermatology News and Research

FDA grants marketing approval for VALCHLOR gel for treatment of early stage CTCL

Ceptaris Therapeutics, Inc., a privately held, specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration has granted marketing approval for the orphan drug VALCHLOR (mechlorethamine) gel for the topical treatment of stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma in patients who have received prior skin-directed therapy.

26 Aug 2013

MC1R mutation responsible for red hair phenotype also promotes cancer-causing pathway

A person's skin pigment, which determines hair color and skin tone, is influenced by the melanocortin-1 (MC1R) gene receptor. For the population's one to two percent of redheads, a mutation in MC1R accounts for their red hair color and typical light skin.

23 Aug 2013

Nuvo: FDA accepts to review New Drug Application for PENNSAID 2%

Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10 today announced that its U.S. licensee for PENNSAID (diclofenac sodium topical solution) 1.5% w/w and PENNSAID 2% (diclofenac sodium topical solution) 2% w/w, Mallinckrodt has advised that the U.S. Food and Drug Administration has accepted for filing and review the New Drug Application for PENNSAID 2% submitted by Mallinckrodt on August 7, 2013.

22 Aug 2013

Acne and diet: an interview with Dr Katerina Steventon, Research Fellow, HONEI, University of Hull

The typical Western diet tends to have a high glycemic index. High glycemic index foods are e.g. white bread, processed cereals, snacks, cakes and deserts, sweets and also instant foods like burgers and fried chicken.

20 Aug 2013

Tigercat and Velocity Pharmaceutical announce submission of IND application to FDA for VPD-737

Velocity Pharmaceutical Development, LLC ("VPD") and Tigercat Pharma, Inc., ("Tigercat") announced today the submission of an Investigational New Drug (IND) application to the US Food and Drug Administration (FDA) for VPD-737 for the treatment of chronic pruritus.

19 Aug 2013

Illinois prohibits minors under age of 18 from indoor tanning

Illinois has joined Vermont, California, Oregon, Nevada and Texas by passing legislation that prohibits minors under the age of 18 from indoor tanning. Following similar ordinances recently put in place in Springfield and Chicago, this law is based on significant scientific evidence that links indoor tanning to increased risk of developing melanoma and other forms of skin cancer.

19 Aug 2013

Dermatology researcher receives NIH grant to investigate role of nervous system in psoriasis

Dermatology researcher Nicole Ward, PhD, has earned her third National Institutes of Health grant in a year - including two that scored in the first percentile. With this most recent award, an R21, she will investigate the role the nervous system plays in psoriasis - an inflammatory autoimmune disease characterized by raised areas of red, scaly, itchy and sometimes painful patches of skin.

17 Aug 2013

Dermatologists provide tips to help psoriasis patients

For people with psoriasis, a chronic skin condition, taking good care of their skin can alleviate some of the discomfort that may be experienced, such as itching, cracking and bleeding of the skin. While managing the skin condition can be a challenge, dermatologists provide tips to help psoriasis patients experience relief.

14 Aug 2013

Neuroimaging specialists use tanners to identify whether UV light triggers brain's pleasure sensors

Neuroimaging specialists at UT Southwestern Medical Center are launching the first clinical trial involving frequent and infrequent tanners designed to identify whether UV light triggers the brain's pleasure sensors.

13 Aug 2013

Summer sun rays is one of the best treatments for psoriasis

Sun exposure is usually discouraged due to harmful rays causing skin cancer and premature aging but for the 7.5 million Americans suffering from psoriasis, the sun is a natural medication.

7 Aug 2013

MedPharm receives new patents for MedSpray topical spray-on-film technology

MedPharm Ltd, the topical drug development specialist, today announced it has been granted a series of further patents for its novel MedSpray topical spray-on-film technology for dermatological, topical and transdermal drug delivery.

6 Aug 2013

Symptoms and treatment for facial allergic contact dermatitis

Facial rashes can take on many forms. Whether red, flat, bumpy and dry, or scaly, flaky and itchy, the appearance of a rash on the face can be very distressing.

3 Aug 2013

Castle Biosciences to present DecisionDx-Melanoma test data at Summer Academy Meeting of AAD

Castle Biosciences Inc. announced that data from studies of its DecisionDx-Melanoma test are being presented today at the Summer Academy Meeting of the American Academy of Dermatology. The validation data confirm previous studies showing that the gene expression profile test is a strong independent predictor for classifying which Stage I or II non-metastatic cutaneous melanoma patients will likely recur.

2 Aug 2013

Visual images of skin cancer most effective in prompting skin self-examinations

Seeing pictures of skin cancer motivates people to regularly check their own moles, according to a new research paper from the School of Public Health and Health Systems at the University of Waterloo.

2 Aug 2013

BMC, BUSM and JIPMER to jointly research on tuberculosis

Boston Medical Center and Boston University School of Medicine are partnering with the Jawaharlal Institute of Postgraduate Medical Education and Research to study tuberculosis. This research is supported by a five-year, $2.5 million grant from the Indo-U.S. Vaccine Action Program.

2 Aug 2013

New treatment options give hope to people with psoriasis

Psoriasis expert and researcher Steve Feldman, M.D., says there are many new treatment options giving hope to the millions of people who suffer from the chronic skin condition.

31 Jul 2013

Patients with melanoma brain metastases can be treated with large doses of interleukin-2

In a retrospective study, Saint Louis University researchers have found that patients with melanoma brain metastases can be treated with large doses of interleukin-2 (HD IL-2), a therapy that triggers the body's own immune system to destroy the cancer cells.

31 Jul 2013

Forest Laboratories, Pierre Fabre Laboratories announce that FETZIMA gets FDA approval for MDD

Forest Laboratories, Inc. and Pierre Fabre Laboratories announced today that FETZIMA (levomilnacipran extended-release capsules), a once-daily serotonin and norepinephrine reuptake inhibitor, discovered by Pierre Fabre Laboratories and co-developed by Forest Laboratories, Inc. was approved by the U.S. Food and Drug Administration for the treatment of Major Depressive Disorder in adults.

26 Jul 2013

Bodelin’s ProScope Micro Mobile picks up steam in dermatology

Bodelin Technologies' newly released ProScope Micro Mobile, the first professional-level microscope to be made specifically to attach to mobile devices such as the iPad, iPad mini, iPhone as well as other tablets and smartphones, has been picking up steam in the dermatology, Estheticians and hair restoration industries.

24 Jul 2013

Clinical trial finds that sleep quality impacts skin function and aging

In a first-of-its-kind clinical trial, physician-scientists at University Hospitals (UH) Case Medical Center found that sleep quality impacts skin function and aging.

24 Jul 2013

Dermatology News and Research

Latest Dermatology News and Research

FDA grants marketing approval for VALCHLOR gel for treatment of early stage CTCL

MC1R mutation responsible for red hair phenotype also promotes cancer-causing pathway

Nuvo: FDA accepts to review New Drug Application for PENNSAID 2%

Acne and diet: an interview with Dr Katerina Steventon, Research Fellow, HONEI, University of Hull

Tigercat and Velocity Pharmaceutical announce submission of IND application to FDA for VPD-737

Illinois prohibits minors under age of 18 from indoor tanning

Dermatology researcher receives NIH grant to investigate role of nervous system in psoriasis

Dermatologists provide tips to help psoriasis patients

Neuroimaging specialists use tanners to identify whether UV light triggers brain's pleasure sensors

Summer sun rays is one of the best treatments for psoriasis

MedPharm receives new patents for MedSpray topical spray-on-film technology

Symptoms and treatment for facial allergic contact dermatitis

Castle Biosciences to present DecisionDx-Melanoma test data at Summer Academy Meeting of AAD

Visual images of skin cancer most effective in prompting skin self-examinations

BMC, BUSM and JIPMER to jointly research on tuberculosis

New treatment options give hope to people with psoriasis

Patients with melanoma brain metastases can be treated with large doses of interleukin-2

Forest Laboratories, Pierre Fabre Laboratories announce that FETZIMA gets FDA approval for MDD

Bodelin’s ProScope Micro Mobile picks up steam in dermatology

Clinical trial finds that sleep quality impacts skin function and aging

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Dermatology News and Research

Latest Dermatology News and Research

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in